These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9756268)

  • 1. Persistent pregnanediol glucuronide secretion after gonadotrophin suppression indicates adrenal source of progesterone in premature ovarian failure.
    Sachdev R; Von Hagen S; Kamnani A; Santoro N
    Hum Reprod; 1998 Aug; 13(8):2061-3. PubMed ID: 9756268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of reproductive hormonal dynamics in the perimenopause.
    Santoro N; Brown JR; Adel T; Skurnick JH
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary hormone levels during the natural menstrual cycle: the effect of age.
    Hall Moran V; Leathard HL; Coley J
    J Endocrinol; 2001 Jul; 170(1):157-64. PubMed ID: 11431148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor symptoms but not negative mood in the early perimenopausal transition: Study of Women's Health Across the Nation.
    McConnell DS; Crawford SL; Gee NA; Bromberger JT; Kazlauskaite R; Avis NE; Crandall CJ; Joffe H; Kravitz HM; Derby CA; Gold EB; El Khoudary SR; Harlow S; Greendale GA; Lasley BL
    Maturitas; 2021 May; 147():26-33. PubMed ID: 33832644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve.
    Pal L; Zhang K; Zeitlian G; Santoro N
    Fertil Steril; 2010 Mar; 93(4):1074-9. PubMed ID: 19100532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    Dahl KD; Czekala NM; Lim P; Hsueh AJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue.
    West CP; Baird DT
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):213-20. PubMed ID: 2959405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
    Adekunle AO; Collins WP; Whitehead MI
    Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
    Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
    J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency.
    Pazzagli M; Magini A; Forti G; Bolelli G; Scarselli G; Noci I; Pellegrini S; Rodbard D; Serio M
    J Steroid Biochem; 1987; 27(1-3):399-404. PubMed ID: 3695488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
    Branch CM; Collins PO; Kilpatrick MJ; Collins WP
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
    Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
    Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-ovarian function before, during and after the menopause: a longitudinal study.
    Metcalf MG; Donald RA; Livesey JH
    Clin Endocrinol (Oxf); 1982 Nov; 17(5):489-94. PubMed ID: 6816490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.
    Johnson L; Sammel MD; Schanne A; Lechtenberg L; Prewitt M; Gracia C
    Fertil Steril; 2016 Dec; 106(7):1793-1799.e2. PubMed ID: 27666565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.